Thursday, 29 October 2026 Every NSE & BSE announcement, by company
ALFA Filings Every announcement, straight from the exchange
Business Update

Jubilant Pharmova Business Update

Jubilant Pharmova announced the USFDA classified their Spokane facility as 'Voluntary Action Indicated' (VAI) following a recent inspection. This concludes the inspection review process.

Source

BSE filing, NSE: JUBLPHARMA. Summary written from the filing by ALFA Finder's alert engine.

Read the filing ↗

Jubilant Pharmova Ltd: key numbers

Share price
₹943.90
Market cap
₹15,035 Cr
Revenue (annual)
₹8,280 Cr
Net profit (annual)
₹398.5 Cr
P/E (TTM)
42.7×Sector 46.1×
Promoter holding
47.68%+0.00% QoQ
FII holding
15.37%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

More from Jubilant Pharmova Ltd

All →

Other business update announcements

All →